Key result
IVUS assessment during stent thrombosis revealed underexpansion in 82% of cases, but IVUS use was not significantly associated with reduced long-term mortality (HR 0.4; 95% CI 0.1-1.6; P=0.2).
Why the study?
Does the use of intravascular ultrasound (IVUS) at the time of stent thrombosis improve long-term mortality and major adverse cardiovascular events?
Observational (n=173)
Yes
Does the use of intravascular ultrasound (IVUS) at the time of stent thrombosis improve long-term mortality and major adverse cardiovascular events?
IVUS reveals a high prevalence of stent underexpansion in early stent thrombosis and malapposition in very late stent thrombosis, though its use during treatment did not significantly reduce long-term mortality or MACE.
IVUS use during stent thrombosis treatment should not yet change practice; leaves open whether imaging-guided optimization improves outcomes in prospective trials.
OBJECTIVE: We hypothesized that patients presenting with stent thrombosis (ST) have a high prevalence of stent underexpansion and malapposition when assessed by intravascular ultrasound (IVUS). BACKGROUND: IVUS can provide mechanistic insight into mechanical factors, including stent underexpansion, malapposition, and fracture that may predispose to ST. METHODS: All consecutive cases of angiographically confirmed ST from a multicenter registry (from 2005 to 2010) were reviewed. All IVUS images were reviewed off-line for the presence of stent underexpansion, malapposition, and fracture. Kaplan-Meier analysis was used to determine whether use of IVUS at the time of ST was associated with long-term mortality and major adverse cardiovascular events. RESULTS: IVUS was performed in 32 of 173 subjects with ST (18%). Stent underexpansion was present in 82% of cases and in all cases of early ST, with a mean stent expansion of 0.7 ± 0.23 by MUSIC criteria. Stent malapposition was most frequently observed in very late ST (40%). In-hospital mortality was similar between subjects who had IVUS performed at the time of ST when compared with the non-IVUS group (3.2% vs. 4.3%, P = 0.8). Subjects who had IVUS performed at the time of ST had lower rates of mortality (HR 0.4, 95% CI 0.1-1.6, P =0.2) and major adverse cardiovascular events (HR 0.5, 95% CI 0.2-1.4, P =0.2) at follow-up, but these values were not statistically significant. CONCLUSIONS: There is a high prevalence of stent underexpansion in early ST, while the prevalence of malapposition is higher in very late ST. Use of IVUS during treatment for ST may identify mechanisms underlying the development of ST.
No takes yet. Share an insight, caveat, or question.
Armstrong et al. (2012) conducted an observational in Stent thrombosis (n=173). Intravascular ultrasound (IVUS) vs. No IVUS was evaluated on Long-term mortality (HR 0.4, 95% CI 0.1-1.6, p=0.2). IVUS assessment during stent thrombosis revealed underexpansion in 82% of cases, but IVUS use was not significantly associated with reduced long-term mortality (HR 0.4; 95% CI 0.1-1.6; P=0.2).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: